Testimonial Mining

Capture clinically accurate KOL testimonials and case studies your marketing and sales teams can actually use: drafted with the clinician, reviewed for MLR, licensed for distribution.

Overview

KOL testimonials get stuck in the gap between what the clinician will say in a private call and what marketing can actually publish. The clinician does not have time to write something usable. Marketing cannot put words in the clinician's mouth. So the testimonial never ships.

We bridge the gap. Working from real engagement notes, we draft testimonials and case studies with the clinician, drive them through your Medical-Legal-Regulatory review, and secure proper licensing for sales and marketing distribution.

Our Process

  1. 1

    Quote sourcing

    Identify quote-worthy moments from existing engagement logs.

  2. 2

    Co-drafting session

    30-minute working session with the KOL to draft the testimonial in their voice.

  3. 3

    MLR submission

    Submit through your existing Medical-Legal-Regulatory workflow.

  4. 4

    Licensing agreement

    Secure written usage rights with explicit scope, duration, and termination terms.

  5. 5

    Distribution

    Hand off polished assets to marketing, sales enablement, and investor relations as scoped.

Frequently Asked Questions

Will KOLs really sign over usage rights?

Yes, when the asset is drafted with them, accurately represents their experience, and the licensing scope is reasonable. Refusals happen. We move on without burning the relationship.

Who owns the assets?

You do, within the licensed scope. KOL retains rights to their own clinical conclusions.

How does this interact with MLR?

Every asset goes through your existing MLR workflow. We provide the materials; we do not bypass review.

What about anonymized case studies?

Possible and sometimes preferable: anonymized case studies can ship faster, though they carry less brand weight.

Turn KOL conviction into shippable assets.

Share your current testimonial inventory and your MLR turnaround time. We will return a quarterly asset production plan.

Start a Conversation